+987.9%
MRNA vs SBAC
+2.4%
+985.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +5.8% | +7.3% | +12.1% |
| 7D | +20.6% | +5.8% | +14.8% | +19.6% |
| 30D | +27.1% | +20.8% | +6.3% | +23.3% |
| 3M | +353.4% | +4.8% | +348.6% | +348.4% |
| 6M | +446.3% | -9.1% | +455.4% | +445.5% |
| YTD | +776.2% | +3.1% | +773.1% | +793.9% |
| 1Y | +987.9% | +2.2% | +985.7% | +1,037.7% |
| All | +987.9% | +2.4% | +985.5% | +1,037.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling